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Editorials
Science-in-brief: What is needed to prevent tendon injury in
equine athletes? A conversation between researchers and
industry stakeholders
Introduction
Superﬁcial digital ﬂexor tendon (SDFT) injury affects up to 30% of
Thoroughbred racehorses and other high-level equine athletes and is both
exercise and age related; high incidence, prolonged periods out of work,
high retirement rates and animal welfare implications are continuing
signiﬁcant problems for equine industries [1,2]. The SDFT is an
energy-storing structure essential for efﬁcient high-speed locomotion, with
narrowmechanical safety margins. Our understanding of pathophysiology
has advanced signiﬁcantly, but preventative measures have not been
developed. Most injuries occur during athletic activity following undeﬁned
periods of matrix microdamage accumulation that is not repaired (and
possibly directly contributed to) by tendon ﬁbroblasts and other
endogenous cellular populations. Detection and/or prevention of the
earliest phases of pathology are likely to have a greater effect than
improvements in therapy, given that tendon is a slowly healing and poorly
regenerative tissue.
This workshopwas held in October 2012 at the University of Glasgow, UK
to bring a key group of scientists from different disciplines (including cell
biology, pathology, bioengineering and physics) together with industry
end-users, including veterinarians and trainers. We had a particular focus
on the Thoroughbred racehorse and the cell biology of normal and injured
tendons. The workshop was funded by the Biotechnology and Biological
Sciences Research Council (BBSRC) under the International Workshops
scheme.
Discussion focused on three main questions.
• What would trainers ﬁnd useful and practical in terms of preventing SDFT
injury?
• Are there available or emerging technologies that could assist in
detection, understanding and prevention of early exercise-induced
pathology?
• What are the best cell culturemodels to test preventativemechanisms in
the laboratory, and how can this be extrapolated back to the living
tissue?
The following is a summary of the discussion points and review of key
concepts, including indications of areas in which signiﬁcant progress is
required.
At the track
It is recognised that racehorse trainers differ signiﬁcantly in their
approaches, attitudes and situations, as is reﬂected by variation between
them in incidences of tendon injury [1,2]. This is a complex issue, but a
large component of the variation relates to the type of racing (e.g. National
Hunt vs. ﬂat racing), including the ages and ‘types’ of horses involved and,
potentially, the progression and/or nature of the pathology itself. In
general, J. Givens (Thoroughbred racehorse trainer and veterinary
graduate) felt that trainers would be far more interested in measures to
prevent SDFT injury than to treat it, due to the signiﬁcant effects on athletic
careers. This is because there is clear recognition in the industry of the
binary nature of this condition, i.e. a tendon cannot be ‘a little bit’
damaged; however, the situation may be different for owners using horses
for recreational purposes/companionship. Any preventative measure that
would signiﬁcantly reduce injury risk (e.g. by 70%) would be likely to be
adopted. It also needs to be kept in mind that the SDFT is not the only
injury-prone structure to be concerned with, and that there are signiﬁcant
commercial pressures to develop horses and allow them to achieve their
athletic limits.
What increases the risk of tendon injury, from the
trainer’s perspective?
Many factors that might be important in determining injury risk have not
been studied in detail, or the information has been conﬂicting. These
factors include track surface conditions, the speed achieved (higher being
more risky), the level of ‘ﬁtness’ of a horse and its conformation. Data on
relationships between track surface condition and/or type and racehorse
injuries are incomplete and often conﬂicting. This is, in part, due to the
very complex interactions between surface type (e.g. wood chip, waxed),
the time taken for it to ‘bed in’, its age, amount of usage, amounts
of organic matter that become incorporated (into artiﬁcial surfaces), the
level of maintenance (which can be highly variable) and ambient
conditions (e.g. temperature, humidity) [3]. It is possible that if the training
surface is highly consistent, it will not be seen to play an important role in
differences in SDFT injury risk (between horses). However, racing itself
occurs on turf in the UK at least (and some horses train on it), and its
condition is enormously variable. We do have some information, e.g. a
higher risk of tendon injury in the UK has been associated with ﬁrmer
racing surfaces and with racing in the summer [4,5]. Slipperiness is
another factor that may be more important on turf racetracks, where
water is applied to achieve consistent ‘going’ conditions and is not really
replicating rainfall (i.e. creating variable surfaces). Where synthetic
surfaces are used during training or racing, high or low temperatures can
alter these surfaces and the associated racehorse speeds (e.g. by thermal
transformation of wax) [6]. Additionally, we know that the SDFT core
becomes hyperthermic during galloping due to loss of some energy as
heat during elastic recoil [7]. Insulation of the limb might add to this
thermal burden. Core hyperthermia of the SDFT in relationship to
environmental temperatures and limb insulation has not been measured.
In fact, a large number of very complex horse and management factors
interact with external conditions. It is extremely difﬁcult to relate tendon
injury risk to previous training and racing history, because better horses
tend to race less frequently (4–5 races per year), while the less ‘talented’
could race up to once a week. Simple comparisons of ‘good’ and ‘average’
horses are difﬁcult, because a horse that is racingmore often is likely not to
be trained as hard. This is additionally complicated by differences between
racing and training; speeds at which horses run will often be higher on the
racetrack. This means there is a possibility that most SDFTmicrodamage is
accumulated during racing, and also that training exercise may not be
sufﬁciently intense to induce injury resistance (if such adaptation is
possible). Other horse factors, including conformation, are difﬁcult to
assess objectively, but there are some clues, e.g. SDFT injury risk has been
associated with increased metacarpophalangeal angle [8]. Factors that
seem to be important for human athletes, such as ‘running style’, are
difﬁcult to measure or change in horses.
What might be done to prevent
tendon injuries?
Injuries to the SDFT are frequently noticed 6–10 days following racing, the
evening after the horse resumes training. It is possible that many lesions
are initiated during a race (or an episode of training in which similarly
‘stronger’ exercise is undertaken), but develop further to a grossly
observable level with some further activity. Detection relies on personnel
feeling for swelling; however, while some gains could bemade by providing
education, this is a very advanced stage of injury, in which some
microdamage has already occurred.
Imaging of preclinical changes: A key problem in all research approaches,
including those discussed below, is the detection of subclinical pathology
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in its very earliest stages, which requires: 1) affordable, noninvasive and
objective detection methods; and 2) a means of their application by
veterinary surgeons, which may require a change in culture such that fees
are based on a ‘herd health’ approach. Signiﬁcant amounts of work would
still be required to link factors responsible for lesion development with
measures to prevent their further progression or to reverse the pathology
(if that is possible). These might include training regimens, optimal surface
choices and correct frequency of racing. The implementation of some
practices, e.g. application of cold boots following exercise (if that were
proven to be preventative), might be impossible for every horse in the
training/racing environment. In terms of reversibility of injury, trainers and
veterinarians often notice transient SDFT swelling in young horses. We
need a better understanding of whether this is a different form of
pathology (i.e. not chronic and progressive degeneration), why it subsides
and/or if the risk of SDFT rupture is higher later on.
Individual optimisation of training regimens: Exercise speciﬁcally to induce
SDFT adaptation has been a research focus, particularly early in life,
although there has been debate about sufﬁciency levels/intensity of
exercise provided to experimental animals, including foals and racehorses.
Adaptive change has not been found, other than a more rapid growth in
SDFT cross-sectional area, but there was also no evidence of pathology;
additionally, there was a later occurrence of musculoskeletal injury (in
general) once these horses were in the racing environment [9–11]. Further
study of early exercise would require interaction of researchers with stud
farms aswell aswith the trainers. Once horses are in the yard, there are few
data available, and it is not certain when horses should ideally start racing
or what happens in response to different exercise regimens. It is possible
that tendons cannot adapt at all. This is complicated by high individual
variability (e.g. in SDFT cross-sectional area, towhich relative contributions
of genetics and exercise are not known) and our lack of knowledge
regarding the most important elements of exercise. For example, the
results of recent work using human subjects suggest that low-volume but
high-intensity exercise is sufﬁcient for aerobic ﬁtness, although admittedly,
the musculoskeletal effects are not known [12]. There may be a delicate
balance, because in some studies the total amount of high-speed exercise
during training has been associated with increased risk of injury [13].
Maintaining a certain frequency of exercise may also be important. This is
supported by ﬁndings in human athletes, in whom any return to training
requires correctly spaced exercise of appropriate intensity, i.e. ‘tendons
don’t like rest or change’ (Jill Cook, cited in [14]). In terms of change, it is
important to know whether training on one surface vs. a variety of them is
advantageous or not. Other issues include weights carried due to
handicapping, jockey weights, tack weights and the more esoteric issue of
mental attitude (‘the art part of the art and science of training’).
Genetic testing and biomarkers: At least some breeders would be likely to
use tests that genuinely indicate injury risk. However, much of the variance
in the likelihood of SDFT injury is probably not genetic. Biomarkers
indicating early pathology would have a far greater appeal for the industry
due to the practicality vs. imaging (as frequent scanning of all tendons is
not realistic) and the minimally invasive nature of blood sampling. In this
respect, one could envision biomarker analysis in the context of a ‘stress
test’ (i.e. pre- and post exercise sample comparison), with equine-speciﬁc
protein arrays and a system such as the Luminex platform [15]. In this way,
a horse can act as its own control, which is a situation that may negate
aspects of genetic variation.
How could cooperation with trainers be obtained,
for research with impact?
Most of the practical problems involved in developing realistic preventative
measures relate to this high-pressure environment, including owner
attitudes; the shorter career for ﬂat-racers can be a particular issue if,
for example, rest periods are required. Another possibility in terms of
practicality could be to employmodelling techniques (for which some data
already exist) to identify individuals at increased risk of SDFT injury, and
then focus resources and time on those animals.
Studies of training regimens: Trainers are not going to standardise training
regimens to test their effects; however, developments in global positioning
system (GPS) and various portablemonitoring devices (e.g. heart monitors)
will now allow more accurate measurement of the training effects.
Practically, researchers will need to support regular inputting of these data
into databases and analytical software. Other aspects, including weather
and track surface conditions, would also need support, i.e. in order to
generate any meaningful data on training vs. SDFT injury that takes into
account the various complexities introduced above, there will need to be
large-scale, researcher-staffed studies that do not interfere with the
day-to-day activities in training yards.
Biomarker development: This is an area in which trainers would be likely to
participate, particularly if the trials did not involve an increased cost of
routine blood sampling. If researchers could provide potentially good
markers for early injury, there is likely to be cooperation in sampling those
horses in which the work rate is being ‘stepped up’ and to alter training
regimens in horses where early damage is indicated. The potential
reversibility of early injury is of great interest to the industry. The onus is on
researchers to provide useful candidate markers, and this is an active area
of research. The challenge is to validate markers reﬂective of changes
speciﬁcally in the SDFT, in a background of products from all of the other
tendons and connective tissues. In all likelihood, biomarker analysis in the
future will be part of a ‘phenotype’ put together from imaging + biomarkers
+ aspects of the physical examination.
But what happens if injuries are discovered?: There is a major issue in
conducting this research, in terms of the implications (perhaps in future
terms) of whether subclinical injury should be reported. There would be
resistance to open reporting of this type of information in many countries.
In Hong Kong, mild tendon injuries are now reported to the public, and the
result of this was more rapid intervention to deal with early injury. This led
to a 20% reduction in retirements from racing due to tendon injury. It might
be very positive for equine welfare and public engagement if there was a
more open policy; this raises the question as to whether prevention
research should be conducted in countries where that attitude exists
and/or greater funds are available within the industry.
Horse-side
There are signiﬁcant gaps in our knowledge of what occurs within
injury-prone SDFT sites (i.e. the metacarpal core) during exercise, how this
is altered by the multiple external and internal factors discussed above
(including exercise type, intensity, duration and frequency), how/why early
pathological change develops and whether (up to a certain point) the
pathology is reversible. This information is clearly required to develop
scientiﬁc rationale for preventative methods, both at horse level and in our
laboratory models.
What should be measured?
Structural changes in the SDFT prior to macroscopic swelling will most
probably represent late phases of subclinical damage, but do require
deﬁnition in terms of understanding the full spectrum of injury. In terms of
the tendon environment, hyperthermia was measured in the SDFT core in
one study but not analysed any further in relationship to various
environmental, exercise and horse-related conditions. Another important
factor never directly measured is the level of oxygen; tendon is not highly
vascular (relative to other tissues). Tendons are comprised of fascicular
subunits, movement between which is an important determinant of
elasticity of this energy-storing structure [16]. These fascicles are formed
by collagenous matrix (and lesser amounts of noncollagenous matrix) that
is synthesised and maintained by the widely separated and longitudinally
oriented rows of tenocytes. The vascular supply is located in loose
connective tissue (the endotenon) that separates fascicles, i.e. most
tenocytes are not directly adjacent to any blood vessels. Exercise-induced
hypoxia or ischaemia-reperfusion has frequently been proposed as a factor
in tenocyte damage and death, due to generation of reactive oxygen
species, high levels of which lead to oxidative stress [17]. Hyperthermia
also increases levels of reactive oxygen species. Reported effects of
hypoxia on cultured tendon cells have been highly variable, i.e. apoptotic
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cell death [18] vs. high tolerance (even of anoxia). However, we have not
been able to plug real-life oxygen and temperature levels into these
systems. The responses of tendon cells to tissue conditions that occur
during exercise/damage (as well as a better idea of what these conditions
are) also require further analyses if we are to validate laboratory models
and study mechanisms. These models should include synthesis of
collagenous and noncollagenous matrix components. We know, for
example, that amounts of type III collagen (which forms weaker,
small-diameter ﬁbrils than the usually predominant type I) can accumulate
in the later stages of preclinical damage in the SDFT core [19]. However,
this raises a signiﬁcant problem for researchers in terms of what cellular
populations to monitor and how to do so. There are different populations
of ﬁbroblastic cells within fascicles (the tenocytes), between fascicles in the
endotenon and within sheaths (the epitenon and paratenon). The
paratenon is a loose external sheath in areas where there is no external
synovial lining, including themetacarpal region of the SDFT. The paratenon
is most easily accessible and is known to contribute cells that proliferate
and migrate into injured tendon substance [20], but we do not know
whether or to what extent this occurs in early subclinical injury. Mechanical
factors are signiﬁcant drivers of cellular phenotype; cells in the dynamic
endotenon environment between sliding fascicles are likely to have
very different turnover and activity levels from tenocytes that sit within
a narrow niche inside dense, longitudinally oriented collagenous
matrix. Levels of 14C in the Achilles tendon of people alive during nuclear
bomb tests (1955–1963) indicated that the tendon core is essentially
not renewed following maturity [21], and this correlates well with an
estimate of collagen half-life of 197.5 years in the equine SDFT [22].
However, the thin endotenon layers have not been analysed separately.
We know, for example, that noncollagenous matrix components (e.g.
glycosaminoglycans, proteoglycans) alter with exercise in the SDFT [23],
and it is possible that this is occurring speciﬁcally within the interfascicular
compartment [24]. Lubricin is a glycoprotein found to be important in
interfasicular movement and surface gliding in other species [25], but it has
not yet been investigated in the horse, nor have other cell types, including
endothelial cells, immune system cells (e.g. mast cells), elements of the
neural system containing neuropeptides (e.g. substance P) and stem cells
(tendon or tendon sheath origin).
How do we make these measurements?
The subjectivity of ultrasound image interpretation is a problem, and there
are other signiﬁcant limitations, including resolution that does not extend
beyond relatively large structures, such as fascicles. Not every change will
be observable, e.g. a tendon core containing signiﬁcantly elevated
amounts of type III collagen can have ultrasonographically (and even
histologically) normal ﬁbre alignment. However, there are signiﬁcant
advantages to being able to image the whole tendon, and there have
been recent technological improvements, i.e. the ultrasound tissue
characterisation technique, which has been used to detect early
pathology in human tendons and reversible post exercise changes in
Thoroughbreds 1–2 days post racing [26,27]. No ultrasound tissue
characterisation–histological correlation has been performed using horse
tendons. The use of magnetic resonance imaging has been more
controversial due to lower structural resolution, but there is at least the
potential to pick up subtle change, and improvements in software are
occurring that may facilitate this. Power Doppler has already been used to
monitor blood ﬂow velocity in the human Achilles tendon during exercise
[28]. Photoacoustic imaging has been used to monitor microvascular
changes in healing Achilles tendons of mice [29], but has not been applied
to larger animal models or preclinical phases. This involves using a pulse
laser source to excite the tissue, which then generates ultrasonic waves
due to thermoelastic expansion. When considering the whole tendon,
biomechanical approaches provide further noninvasive possibilities.
However, although various combinations of techniques, including force
plate measurements, kinematic analysis and dynamometry, have been
used to monitor healing equine and human tendons, their applicability to
the detection of early pathology is uncertain. Biomechanical normality
does not imply structural and functional normality; in part, this can be due
to the adaptation of other structures in the limb.
For measurement of oxygen levels, the blood oximetry technique is one
possibility [30,31]. The technique will work through skin, involves
transmitting and receiving probes that can be as small as 1 mm3, and has
been used to assess the human Achilles tendon [32].
Monitoring cellular activity, particularly in different tendon
compartments, raises further technological challenges. Positron emission
tomography involves detection of γ-rays emitted indirectly by a tracer that
is injected into the body, such as an analogue of glucose (ﬂudeoxyglucose)
to measure tissue uptake; imaging is frequently achieved using a
computed tomography or magnetic resonance imaging system. Various
markers could be used, including those relevant to hypoxia and
inﬂammation. While expense currently limits its use in horses, there
has already been interaction between veterinary researchers and
scientists/medical clinicians with access to such facilities. For more direct
measurement, it is obvious that the paratenon can be accessed with
relative ease. Signiﬁcant exercise-induced changes in type I collagen
turnover were measured in the paratenon of the human Achilles tendon
using aminimally invasivemicrodialysis technique [33] that would be easily
applicable to horses. Other compartments could only be accessed with
signiﬁcant tissue damage, and their investigation is likely to be limited to in
vitro/post mortem studies.
What about biomarkers – ‘the holy grail’?
This was clearly expressed as an interest for trainers, andwould potentially
avoid the difﬁculties of imaging. As yet there are no clear individual
candidates. Cartilage oligomeric matrix protein [34] and neoepitopes
(cleaved matrix proteins generated during injury) are of use only when
measured in synovial ﬂuid adjacent to a clinical injury, i.e. they are not
applicable to subclinical metacarpal region SDFT pathology. The approach
of measuring multiple blood markers simultaneously to obtain a
‘phenotype’ is more likely to be useful, but there is still the potential
problem of tissue speciﬁcity (discussed in ‘Biomarker development’).
Multiplex assays that allow simultaneous measurement of multiple
analytes (nucleic acid or protein based) in a single run may increase the
affordability. Potential difﬁculties include optimal storage requirements
(-80°C without repeated freeze-thawing), regular sampling of horses and
availability of reagents for equine use (researchers have to routinely
perform such validations). It should also be kept inmind that predictions of
injury risk are likely to lose accuracywhen applying these data to individual
horses. Greater advances havebeenmade in themedical ﬁeld in this type of
proﬁling, e.g. using serum and synovial levels of multiple cytokines to
identify early stages of osteoarthritis [15]. There is some recent information
on the relationship between genotype and tendon injury, but it is not
currently of practical use. We do not yet knowwhy (in horses and humans)
there is a higher injury risk associated with certain polymorphisms in the
minor matrix components collagen type V and tenascin [35].
In the laboratory
Given the current limitations in technology and biomarker information, in
particular at the tendon compartment/microscopic level, there is a
necessity for in vitro work to provide scientiﬁc rationale for industry
involvement in the development of preventative measures. However,
there are signiﬁcant problems with the relevance of systems used in our
laboratories, due to the complex multilevel structure of tendon tissue and
the environment that it experiences during and after high-speed exercise.
Results can also be difﬁcult to relate back to the tissue, with problems in
accessing sufﬁcient numbers of post mortem samples from horses with
deﬁned exercise/racing histories and in consolidation of expertise to
conduct appropriate analyses.
What is currently limiting the relevance of our cell
culture models?
The very different arrangement of cells in tendon tissue vs. the culture dish
is a major problem. In tissue, the tenocytes are arranged in rows within
large amounts of matrix, and there is still some confusion as to what their
cytoplasm looks like in 3 dimensions (largely not seen histologically), i.e. in
the form of sheets or ﬁne processes. This has also not been deﬁned in
immature and injured tendons (cell rich) vs. normal adult tendon (cell
poor). We are also not certain what cellular populations are derived when
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tendon specimens are digested or when cells are grown from explants.
There is no speciﬁc marker for tenocytes; they do express scleraxis (a
marker of tendon development), but the same marker is upregulated
during injury by other ﬁbroblastic cells (and digestion and cutting of tissue
are both injury events). We do not know how mixed the original cells are,
and what we are selecting for in cell culture conditions (particularly with
repeated passaging). It is possible to separate the paratenon and epitenon
from the tendon substance, and differences in collagen I and III synthesis
have been found in other species between cultured tenocytes, epitenon
ﬁbroblasts and synovial cells. These cellular compartments also require
investigation in situ in tissue specimens (e.g. matrix gene and protein
expression) to determinewhether the differential phenotype is maintained
in culture conditions. There is also some confusion as to whether
tendon-derived stem cells are being isolated. Multipotent populations
have been isolated [36], but even tenocytes in situ show phenotypic
plasticity in response to damage and/or mechanical environment
alterations. The relationship of these events to the cell culture environment
and the disease status of the original tissue has not been investigated. For
example, synovial mesenchymal stem cells/progenitor cells from human
patients with osteoarthritis do not show self-aggregation due to cytokine
exposure, including macrophage chemoattractant protein-1 [37]. This
comes back in a circular way, to being able to deﬁne early pathology in
SDFT tissue used for laboratory studies. Findings for human and sheep
stem cells [37,38] support the point that perhaps tendon stem cells cannot
function well in the injury environment. Control of this tissue environment
may be required to realise the full potential of endogenous or injected
mesenchymal stem cells/progenitor cells in optimising repair.
The problems with cell culture
laboratory dogma
Standard approaches used in cell culture laboratories are not ideal formost
cells, but tendon cells may be having more extreme responses to the cell
culture conditions, perhaps due to their origin from a particularly highly
specialised tissue environment. Although 21% oxygen is typically used,
most cells in culture are damaged by it because tissue levels are ∼2–7%,
with tendons likely to be towards the bottom of that range. Reduced
oxygen levels can be achieved using extremely inexpensive systems [39],
with 5% being a ‘safe’ level for tendon cells. There are also problems in
terms of assessing stress in cells due to abnormal cell culture conditions
and how these interfere with studies of natural injury-inducing factors
found in tendons (hypoxia, hyperthermia,mechanical strain and cytokines).
A panel of markers for horse cell stress responses is not currently available
for interrogation in various systems and conditions, for relating back to
normal and injured SDFT tissue. Promyelocytic leukaemia protein is a
potential candidate for the central coordinator of stress protein responses.
In humans it is complex, with at least 20 isoforms; it has not been studied in
the horse. Most researchers do not monitor cell stress in their systems,
with assumptions that continued viability is sufﬁcient. It can be monitored
very simply by immunolabelling for gammaH2AX, a histone protein that
responds to DNA damage. Cell stress is often seen as DNA damage even if
this was not the primary injury [40]. The reversibility of stress responses is
highly variable, but dependent on the stress type, cell type and cell culture
‘ageing’ effects (due to expansion, not the age of the source animal). A
further important consideration when assessing cell stress responses is
that the cells are a population and will not all respond in the same way.
Variation may also relate to the point in the cell cycle when they are being
observed. It is therefore important to capture all data and not to eliminate
‘outliers’ as statistically inconvenient [40]. The presence of stem cells will
make any variation evenmore extreme, because they include subsets with
differential responsiveness at many levels to multiple factors; while this
diversity is a ‘complication’ when trying to obtain data, it ismost likely to be
a strength within the tissue, just as it is for immune system cells.
Most work on cell stress using nontendon cells has not focused on
effects of the mechanical environment, extracellular matrix composition,
matrix stiffness and morphology, or interactions of those factors with
cytokines. Tendon cells are signiﬁcantly damaged when grown on glass or
plastic that has not beenmatrix coated. There has also been no study of the
relationship between nuclear shape and stress. Nuclear shape is altered
by cyclical deformation, is known to be different in degenerating/
microdamaged tendons [41], and inﬂuences gene transcription and
epigenetic control mechanisms. Some of these problems in the 2D system
might be mitigated by growing cells on (cryosectioned) acellularised
tendon matrix from the same or a different horse; they attach, proliferate,
migrate at least a short distance into the matrix, elongate along the ﬁbres,
and have collagen gene expression levels more comparable with cells in
tissue [42].
Would 3D systems be better?
The advantage of 2D systems discussed in ‘What is currently limiting the
relevance of our cell culture models?’ is that they are easier to establish,
manipulate and (usually) image, but are really only of value for screening,
before conﬁrming any ﬁndings in more complex (i.e. relevant) models. The
problem is that in tissue, the cells are found in multiple compartments in a
multilevel structure (including fascicles and fascicular bundles) with other
cell types; many aspects of the structure and cells are likely to differ
signiﬁcantly between individuals, with age and in different injury states.
This may include the size and nature of the cellular networks. We cannot
replicate that with 3D cell-matrix constructs, but we can provide 3D rather
than one-sided engagement of the focal adhesion kinase system, more
realistic relative amounts of matrix and (potentially) seeding with multiple
cell types (e.g. tendon cells with mast cells or macrophages). Bioartiﬁcial
tendons can be made with relative ease [43]. Another method involves
mixing tendon cells into collagen or ﬁbrin gel and allowing them to contract
the matrix [44]. The remodelling is reliant on endogenous loading by
ﬁbroblasts; it is matrix metalloproteinase dependent, and the matrix has a
more ‘natural’ organisation. Such systems have not been created and
compared using cells from the SDFT and other digital tendons for
validation; phenotypic differences of SDFT and common digital extensor
tendon cells have already been demonstrated in situ and inmonolayer (2D)
culture [45,46].
A further option is to use tissue explants. These have been used
successfully to address questions in a way that would not be possible with
matrix-free cells [47–49]. However, a signiﬁcant disadvantage is that they
are injured on removal. Some of the explants die very rapidly, while in those
remaining viable, there will be cell death on the outside due to trauma.
Gene expression alters markedly, and it is not certain whether this returns
to normal levels. The thickness of explants is limited to <2 mm due to
perfusion limitations. There is an advantage to the low metabolic rate in
this tissue, in that when it is kept chilled (4°C) for periods of up to 10 days,
a lot of the ribonucleic acid (RNA) is still intact and cells may still be
cultured. The use of chilling and other methods to reduce injury and
normalise explants have not been investigated.
If the mechanical environment is not recapitulated,
is cell culture relevant?
Tenocytes seem to have amechanostat set point (i.e. an ideal level of strain
depending on the tendon of origin), but this does alter with strain
deprivation over a certain period of time [50]. The tenocytes have cilia, the
deﬂection and length of which is modulated by tensile loading [51]. These
have not been studied in horses but might be of use to establish the
normality of in vitro strain environments. The zero-strain environment that
most cells experience in culture is not desirable, because tendon cells
express matrix metalloproteinases in that state [47,52]. The commercially
available Flexcell system is one means of applying static or cyclical strain,
either to monolayers on deformable membranes (with a recognised ‘edge
effect’) or bioartiﬁcial tendons. Othermethods have been used to test both
bioartiﬁcial tendons and explants/fascicles, including Bose system
adaptations or custom-made systems. Technical issues can include the
following: effects and efﬁcacy of gripping the ends; keeping specimens
moist (with ﬂuid affecting optical measurements); rupture due to
cell-induced rather than externally applied tension; and visualisation of
cells under strain (this is possible under slow or incremental strain) [53].
The effects of mechanical strain on tendon cells are well known, and the
cells in bioartiﬁcial tendons have been shown to become more ‘tenocyte
like’ with application of cyclical strain [43]. However, there is still a problem
when determining which strain environments stimulate optimal tenocyte
differentiation or stress, i.e. this may not correlate with responses that
would occur in vivo.
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Important research themes
The following themes were considered to be some of the most important
directions for research into the prevention of SDFT injury in equine athletes
in the immediate future.
• Track-side and horse-side:
○ Large-scale studies appropriately staffed by researchers (this would
presumably need to be multi-institutional) to identify associations
between multiple factors and SDFT injury occurrence (e.g. track
surface conditions, weather, speciﬁc training regimens and individual
horse factors), including the use of GPS systems and other monitors.
○ Investigation of early exercise (andmental attitude) of foals relative to
subsequent performance, i.e. interacting with stud farms.
○ Further development of imaging strategies for detection of early
pathology in conjunction with medical colleagues and including,
but not limited to, ultrasound tissue characterisation, magnetic
resonance imaging and power Doppler techniques.
○ Consideration of using other training environments that might be
more practical, e.g. eventing yards.
• Horse-side and in the laboratory:
○ Examination of large numbers of SDFT samples from horses of known
training/racing history to identify early pathology (again this would
need to be multi-institutional and include multiple techniques).
○ Development of multiplex tests to identify blood-based phenotypic
markers of early injury (to be related to the tissue study above) prior
to ﬁeld studies. This could potentially include modelling of horses
most at risk in order to focus the sampling.
○ Measurement of the SDFT environment during exercise, including
oxygenation (oximetry), temperature and cellular activity (e.g. by
paratenon dialysis, positron emission tomography scanning) for
application to cell culture models.
○ Development of a panel of cell stress markers for the horse, and
determination of the effects of multiple factors, including those
measured in vivo (above), cell culture stress, matrix type and nature
and injury status of the original tissue.
○ Reﬁnement of cell culture models, including study of paratenon and
epitenon cells separately, further investigation of the acellular matrix
method, validation of 2D data in 3D systems, improvement of explant
viability and application of cyclical strain.
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